CoChat

Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease

Open access
Apel, J., Reutrakul, S., Baldwin, D. · 2014 · Clinical Kidney Journal

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Hypoglycemia is common in patients with end-stage renal disease (ESRD). We identified the incidence and timing of hypoglycemia and its risk factors in hospitalized patients with ESRD after the treatment of hyperkalemia with insulin. METHODS: We conducted a retrospective study of all hospitalized adult patients treated with hemodialysis who received intravenous insulin to treat hyperkalemia between 1 January 2011 and 31 December 2011. We identified patients who became hypoglycemic [blood glucose <3.3 mmol/L (60 mg/dL)] after insulin administration. RESULTS: Two hundred and twenty-one episodes of hyperkalemia were treated with insulin, resulting in 29 episodes of hypoglycemia (13%). Factors associated with a higher risk of hypoglycemia included no prior diagnosis of diabetes [odds ratio (OR) 2.3, 95% confidence interval (CI) 1.0-5.1, P = 0.05], no use of diabetes medication prior to admission [OR 3.6, 95% CI 1.2-10.7, P = 0.02] and a lower pretreatment glucose level [mean 5.8 ± 0.7 mmol/L (104 ± 12 mg/dL) versus 9.0 ± 0.6 mmol/L (162 ± 11 mg/dL), P = 0.04]. Hypoglycemia occurred at a median of 2 h after insulin administration and persisted for a median of 2 h. CONCLUSIONS: The treatment of hyperkalemia with insulin in hospitalized patients with ESRD may be complicated by hypoglycemia. Patients with a history of diabetes are less susceptible to this complication. Our study supports the use of a protocol to provide dextrose support and blood glucose monitoring for at least 3 h after insulin treatment of hyperkalemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ckj/sfu026

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 1

  1. Parham, 2006, Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital, 33, 40

Cited by

See all 69

Metadata

Authors
Apel, J., Reutrakul, S., & Baldwin, D.
Affiliations
  • Rush University Medical Center (US)
  • Mahidol University (TH)
Corresponding author
Apel, J.
Venue
Clinical Kidney Journal
Published
2014-03-18
Volume
7
Issue
3
Pages
248-250
ISSN
  • 2048-8505 (ISSN-L)
  • 2048-8513
OpenAlex
W2150100479
Cited by
67
References
16
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 1 · 2015: 5 · 2014: 2
FWCI
3.47
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Clinical Kidney Journal (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
hypoglycemia, hyperkalemia, insulin therapy, end-stage renal disease, hemodialysis, diabetes mellitus, risk factors, dextrose supplementation, blood glucose monitoring, hospitalized patients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease. https://app.cochat.ai/papers/10.1093/ckj/sfu026
The paper
Apel, J., Reutrakul, S., & Baldwin, D. (2014). Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease. Clinical Kidney Journal. https://doi.org/10.1093/ckj/sfu026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.